NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1760658330 MD
Verify on CMS → Binusha Moitheennazima, MD
Pulmonary Disease Physician in Nacogdoches, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
18K
Medicare Part D claims · 1K beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
77%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.7/100
▲ 14 pts above national avg 83.5 · Exceptional
Industry payments
$1.8K
73 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Binusha Moitheennazima, MD reported a CMS MIPS final score of 97.7/100 - above the 83.5 national average - and filed 18,098 Medicare Part D claims in 2024.
- 97.7/100
- MIPS score · +14 vs avg
- 18K
- Part D claims, 2024
- 77%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Binusha Moitheennazima, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1760658330), first enumerated 05/05/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 18,098 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 97.7/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.8K in reported industry payments (73 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Binusha Moitheennazima, MD's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1760658330 · Pulmonary Disease Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-HEAVY · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1760658330
- ENUM-MID 2008
- TAX-MID 10K Pulmonary Disease
- MIPS-ELITE 97.7/100
- RX-HEAVY 18K claims
- BOOK-LIGHT 600 in Texas
- PHOTO-FINISH John Bloom, MD · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- John Bloom, MD ·…
John Bloom, MD
97.6 MIPS pts
- Gordon Carr, M.D…
Gordon Carr, M.D.
97.6 MIPS pts
- Arista Chand, MD…
Arista Chand, MD
97.6 MIPS pts
- Moitheennazima ·…
Moitheennazima · this provider
97.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Binusha Moitheennazima, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Binusha Moitheennazima, MD sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Binusha Moitheennazima, MD writes more Part D claims than 100% of them and scores higher on MIPS quality than 87% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Binusha Moitheennazima, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Binusha Moitheennazima, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Binusha Moitheennazima, MD?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
18,098 12× vs specialty avg
MIPS final score
97.7/100 14.2 pts vs avg
Specialty distribution in Texas
How Pulmonary Disease Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Binusha Moitheennazima, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 97.7/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1760658330 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 05/05/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
97.6529
Final Score
Measured-score avg: 83.5
76.8292
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Binusha Moitheennazima, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Nacogdoches Pulmonary And Sleep Associates PA
Nacogdoches, TX
Texas Specialty Physicians
Palestine, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Binusha Moitheennazima, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.8K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Binusha Moitheennazima, MD. To verify Binusha Moitheennazima, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Binusha Moitheennazima, MD - brand share 22.0%
Pulmonary Disease Physician average
22% brand-name claims vs 77% generic, on 18,098 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
18,098
Total Claims
$2.7M
Total Drug Cost
1,217
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 21,603.8
- Total Day Supply
- 503,813
- Brand vs Generic
- 22% brand / 77% generic
- Brand Drug Cost
- $2.4M
- Generic Drug Cost
- $231K
- Opioid Claims
- 173 (1.0% rate)
- Antibiotic Claims
- 683
Patient Demographics
- Average Patient Age
- 69.8 years
- Avg HCC Risk Score
- 2.14
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 288, 65-74: 523, 75-84: 321, 85+: 85
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Binusha Moitheennazima, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Montelukast Sodium
Montelukast Sodium
2,134 claims
- Fluticasone Propio… 775
Fluticasone Propionate
775 claims
- Prednisone 624
Prednisone
624 claims
- Atorvastatin Calcium 564
Atorvastatin Calcium
564 claims
- Trelegy Ellipta 540
Trelegy Ellipta
540 claims
- Albuterol Sulfate … 496
Albuterol Sulfate Hfa
496 claims
- Furosemide 420
Furosemide
420 claims
- Potassium Chloride 370
Potassium Chloride
370 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 2,134 |
| Fluticasone Propionate | 775 |
| Prednisone | 624 |
| Atorvastatin Calcium | 564 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 540 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 496 |
| Furosemide | 420 |
| Potassium Chloride | 370 |
| Trazodone Hcl | 370 |
| Levocetirizine Dihydrochloride | 322 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Binusha Moitheennazima, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Binusha Moitheennazima, MD's 18,098 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Moitheennazima, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.7 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Moitheennazima.
One of 600 Pulmonary Disease Physician providers enrolled in Texas, 5 are shown here.
Dr. Qammar Abbas
M.D.
Wylie, TX
Dr. Mohamed Abdalla
MD
San Antonio, TX
Dr. Emran Abu Atherah
M.D
Webster, TX
Dr. Muhanned Abu-Hijleh
M.D.
Texarkana, TX
Dr. Bruce Ackerman
D.O.
Garland, TX
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Binusha Moitheennazima, MD's specialty? ▼
Binusha Moitheennazima, MD specializes in Pulmonary Disease Physician and practices in Nacogdoches, Texas. Credentials: MD.
How much does Binusha Moitheennazima, MD prescribe under Medicare Part D? ▼
In 2024, Binusha Moitheennazima, MD wrote 18,098 Medicare Part D claims totaling $2.7M in drug costs for 1,217 beneficiaries.
What is Binusha Moitheennazima, MD's Medicare quality score? ▼
Binusha Moitheennazima, MD has a CMS MIPS Final Score of 97.7/100 (Quality: 76.8). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Binusha Moitheennazima, MD located? ▼
Binusha Moitheennazima, MD is located at 1209 N MOUND ST, Nacogdoches, TX, 75961. Phone: (936) 585-4646.
What is Binusha Moitheennazima, MD's NPI number? ▼
Binusha Moitheennazima, MD's National Provider Identifier (NPI) is 1760658330, issued on 05/05/2008.
Does Binusha Moitheennazima, MD prescribe more brand-name or generic drugs? ▼
Binusha Moitheennazima, MD's prescribing is 22% brand-name and 77% generic drugs by claim count, with $2.4M in brand drug costs.
Does Binusha Moitheennazima, MD prescribe opioids? ▼
Yes, Binusha Moitheennazima, MD had 173 opioid claims in 2024 with an opioid prescribing rate of 1.0%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Binusha Moitheennazima, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Binusha Moitheennazima, MD's most frequently prescribed drugs include Montelukast Sodium, Fluticasone Propionate, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Binusha Moitheennazima, MD accept Medicare? ▼
Binusha Moitheennazima, MD appears in CMS Medicare data with 18,098 Part D claims and 1,217 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Binusha Moitheennazima, MD's credentials? ▼
Binusha Moitheennazima, MD's NPI is 1760658330 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.